Study questions whether mistaken antibodies led cancer research down a 20-year dead end

15 Jun 2017
Science Daily

For nearly two decades researchers have sought a way to target an estrogen receptor in the hope they could improve breast cancer survival, but a new article contends that the effort may never pan out. The reason? The target receptor does not actually appear to be where they believe it to be.

Please click here to read the 'Science Daily' news article in full